Michael E. Coats

3.7k total citations
5 papers, 441 citations indexed

About

Michael E. Coats is a scholar working on Pathology and Forensic Medicine, Virology and Oncology. According to data from OpenAlex, Michael E. Coats has authored 5 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 2 papers in Virology and 2 papers in Oncology. Recurrent topics in Michael E. Coats's work include HIV Research and Treatment (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Viral Infections and Immunology Research (1 paper). Michael E. Coats is often cited by papers focused on HIV Research and Treatment (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Viral Infections and Immunology Research (1 paper). Michael E. Coats collaborates with scholars based in United States. Michael E. Coats's co-authors include Andres Μ. Salazar, Donald E. Goodkin, Alex Martin, M. Campion, L. D. Jacobs, J R Richert, Nancy A. Simonian, W. E. Jones, Jehan Alam and F Munschauer and has published in prestigious journals such as Neurology, Electroencephalography and Clinical Neurophysiology and Multiple Sclerosis Journal.

In The Last Decade

Michael E. Coats

5 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Coats United States 4 258 135 121 96 79 5 441
A. Bellacosa Italy 8 411 1.6× 136 1.0× 80 0.7× 175 1.8× 29 0.4× 8 548
D. Carrara Italy 5 309 1.2× 109 0.8× 57 0.5× 147 1.5× 23 0.3× 5 440
Joseph A. Lopez United States 8 82 0.3× 32 0.2× 25 0.2× 78 0.8× 94 1.2× 14 341
Takayuki Kanai Japan 9 224 0.9× 97 0.7× 53 0.4× 122 1.3× 171 2.2× 17 519
Andreas Lysandropoulos Belgium 11 360 1.4× 49 0.4× 159 1.3× 62 0.6× 131 1.7× 21 521
Joselyn Lindgren United States 10 119 0.5× 20 0.1× 70 0.6× 45 0.5× 14 0.2× 13 837
John R. Rinker United States 12 295 1.1× 72 0.5× 53 0.4× 152 1.6× 209 2.6× 23 654
Marius Birlea United States 12 172 0.7× 31 0.2× 30 0.2× 106 1.1× 97 1.2× 22 418
Damien Biotti France 15 287 1.1× 95 0.7× 55 0.5× 293 3.1× 75 0.9× 61 606
M L Martínez-Ginés Spain 10 194 0.8× 36 0.3× 33 0.3× 52 0.5× 159 2.0× 12 346

Countries citing papers authored by Michael E. Coats

Since Specialization
Citations

This map shows the geographic impact of Michael E. Coats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Coats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Coats more than expected).

Fields of papers citing papers by Michael E. Coats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Coats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Coats. The network helps show where Michael E. Coats may publish in the future.

Co-authorship network of co-authors of Michael E. Coats

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Coats. A scholar is included among the top collaborators of Michael E. Coats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Coats. Michael E. Coats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Herndon, Robert M., Richard A. Rudick, Frederick Munschauer, et al.. (2005). Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis. Multiple Sclerosis Journal. 11(4). 409–419. 54 indexed citations
2.
Rudick, R. A., Nancy A. Simonian, Jehan Alam, et al.. (1998). Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Neurology. 50(5). 1266–1272. 262 indexed citations
3.
Jabbari, Bahman, et al.. (1993). Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects. Electroencephalography and Clinical Neurophysiology. 86(3). 145–151. 35 indexed citations
4.
Martin, Alex, Melvyn P. Heyes, Andres Μ. Salazar, et al.. (1992). Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. Journal of Neuropsychiatry. 4(3). 270–279. 88 indexed citations
5.
Coats, Michael E.. (1985). Meige's Disease and a Positive Treatment Response with Deanol. Military Medicine. 150(3). 152–153. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026